Arthritis can limit daily activities, but the Aging Untold experts say there are effective ways to manage symptoms and ...

Despite incremental gains in awareness and prescribing, most launch metrics continue to trail recent rheumatology benchmarks, ...

Autoimmune and autoinflammatory arthritis are often called "invisible illnesses" because many patients may appear healthy on the outside while silently battling chronic pain, fatigue, stiffness, and ...

AbbVie (ABBV) stock is in focus as UCB's Bimzelx beats the company's immunology blockbuster Skyrizi in head-to-head trial for ...

UCB has announced new week 16 results from the phase 3 BE BOLD trial showing that bimekizumab delivered superior joint ...

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...

Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...

If youve been diagnosed with psoriatic arthritis, you may have heard the term minimal disease activity (MDA). Broadly speaking, this is the goal of treatment and it means that your disease is well ...

A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

Bristol-Myers Squibb Co. earned a federal judge’s final approval of a $239 million class settlement, resolving allegations from investors that acquired company Celgene Corp. misrepresented a multiple ...